The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ERIC CLL 2026 | Understanding the CLL genome: current knowledge and remaining gaps
Anna Schuh, MD, PhD, University of Oxford, Oxford, UK, discusses the current understanding of the chronic lymphocytic leukemia (CLL) genome, highlighting the significant progress made in describing the coding and non-coding genome, epigenome, and insights from single-cell studies. Prof. Schuh notes that collective studies analyzing both the genetic and immunological aspects of CLL are needed to further advance understanding. This interview took place at the 2026 ERIC International Meeting in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
